MH
MP Healthcare Venture Management
Venture CapitalActiveMPH is the venture capital arm of Mitsubishi Tanabe Pharma Corp
30
Investments
7
Exits
—
AUM
23.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for MP Healthcare Venture Management.
Investment Thesis & Strategy
MPH invests in various stages of biotech companies, leveraging its parent company's expertise in the pharmaceutical industry. They seek companies with innovative therapeutic approaches and strong potential for commercialization.
Investment Activity
Deals per year over the last 8 years
1
20151
20161
20174
20181
20192
20201
20211
2022Portfolio Companies
Selected investments from their portfolio of 30 companies
R
Rgenta Therapeutics
Biotech · Series A, 2022
K
Kyverna Therapeutics
Biotech · Series A, 2021
V
Ventyx Biosciences
Biotech · Series A, 2020
L
Lycia Therapeutics
Biotech · Series A, 2020
T
Tessera Therapeutics
Biotech · Series A, 2019
C
Cabaletta Bio
Biotech · Series A, 2018
S
Sana Biotechnology
Biotech · Series A, 2018
V
Vor Biopharma
Biotech · Series A, 2018
C
Cerevel Therapeutics
Biotech · Series A, 2018
O
Obsidian Therapeutics
Biotech · Series A, 2017
A
Allovir
Biotech · Series A, 2016
R
Revolution Medicines
Biotech · Series A, 2015
Frequently Asked Questions
MP Healthcare Venture Management focuses on Series A, Series B, Series C+ stage investments.